Jingrui Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Jingrui Bio General Information

Description

Provider and developer of drug delivery solutions designed for RNAi (RNA interference). The company focuses on liver- specific drug delivery systems for RNAi therapeutic, enabling clients with drug delivery solutions transfer, consulting, and experimental development, with features including scalable production processes, specialized technical services, and a focus on regulatory-compliant operations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 388 Ruoshui Road, Suzhou Industrial Park
  • China (Suzhou Area of China Pilot Free Trade Zone) E406-61
  • Suzhou, Jiangsu 215000
  • China
+86 135
Primary Industry
Drug Delivery
Vertical(s)
Life Sciences
Corporate Office
  • Number 388 Ruoshui Road, Suzhou Industrial Park
  • China (Suzhou Area of China Pilot Free Trade Zone) E406-61
  • Suzhou, Jiangsu 215000
  • China
+86 135

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jingrui Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 07-Apr-2026 Completed Generating Revenue
2. Early Stage VC 05-Sep-2024 Completed Generating Revenue
1. Seed Round 08-Feb-2024 Completed Startup
To view Jingrui Bio’s complete valuation and funding history, request access »

Jingrui Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lapam Capital Venture Capital Minority
Shunwei Capital Venture Capital Minority
Wuhan Zhongxin Ruida Investment Management Venture Capital Minority
Sherpa Healthcare Partners Growth/Expansion Minority
Fosun Health Capital Corporate Venture Capital Minority
To view Jingrui Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Jingrui Bio FAQs

  • When was Jingrui Bio founded?

    Jingrui Bio was founded in 2023.

  • Where is Jingrui Bio headquartered?

    Jingrui Bio is headquartered in Suzhou, China.

  • What industry is Jingrui Bio in?

    Jingrui Bio’s primary industry is Drug Delivery.

  • Is Jingrui Bio a private or public company?

    Jingrui Bio is a Private company.

  • What is Jingrui Bio’s current revenue?

    The current revenue for Jingrui Bio is .

  • Who are Jingrui Bio’s investors?

    Lapam Capital, Shunwei Capital, Wuhan Zhongxin Ruida Investment Management, Sherpa Healthcare Partners, and Fosun Health Capital have invested in Jingrui Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process